The global market for Intravascular Ultrasound (IVUS) was estimated at US$731.8 Million in 2024 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Intravascular Ultrasound (IVUS) market.
The utilization of IVUS has been growing due to its ability to enhance the precision of percutaneous coronary interventions (PCI) and other vascular procedures. The technology is critical in the decision-making process for treatments as it assists in choosing the appropriate size of stents and ensuring their correct placement and expansion. This reduces the risks of complications such as stent thrombosis and restenosis, which are significant concerns in cardiac care. Furthermore, IVUS helps in the assessment of ambiguous angiographic images, offering a more definitive understanding of the vascular anatomy and pathology. As healthcare moves towards more personalized and precise treatment modalities, the role of IVUS in clinical settings has become increasingly vital. This shift is supported by a growing body of clinical evidence that underscores the benefits of IVUS in improving the outcomes of cardiovascular procedures.
The growth in the IVUS market is driven by several factors, including technological advancements, increased prevalence of cardiovascular diseases, and rising demand for minimally invasive procedures. Technological innovations in IVUS systems, such as improved image resolution and user-friendly interfaces, make the technology more accessible and effective for physicians. The aging global population and lifestyle-related health issues have led to a higher incidence of cardiovascular diseases, subsequently increasing the need for advanced diagnostic and treatment technologies like IVUS. Additionally, there is a growing patient preference for minimally invasive procedures, which are less painful, carry fewer risks of infection, and have quicker recovery times compared to traditional surgeries. These factors, combined with supportive government initiatives and healthcare policies promoting advanced medical equipment, are crucial in driving the adoption and expansion of IVUS technologies in medical institutions worldwide.
Global Intravascular Ultrasound (IVUS) Market - Key Trends and Drivers Summarized
Intravascular Ultrasound (IVUS) is a medical imaging methodology used primarily in cardiology to visualize the inside of blood vessels from a catheter inserted into the artery. It provides a unique perspective by offering real-time views of the vessel walls and other structures within the vessels, which is critical for diagnosing and treating vascular diseases such as atherosclerosis. IVUS is particularly useful for assessing the severity of blockages and guiding interventions like stent deployment. By emitting sound waves, an IVUS device produces detailed images of the vessel walls, allowing physicians to observe not just the lumen but also the atheromatous plaque characteristics, providing a much clearer and more accurate picture than traditional imaging techniques such as angiography.The utilization of IVUS has been growing due to its ability to enhance the precision of percutaneous coronary interventions (PCI) and other vascular procedures. The technology is critical in the decision-making process for treatments as it assists in choosing the appropriate size of stents and ensuring their correct placement and expansion. This reduces the risks of complications such as stent thrombosis and restenosis, which are significant concerns in cardiac care. Furthermore, IVUS helps in the assessment of ambiguous angiographic images, offering a more definitive understanding of the vascular anatomy and pathology. As healthcare moves towards more personalized and precise treatment modalities, the role of IVUS in clinical settings has become increasingly vital. This shift is supported by a growing body of clinical evidence that underscores the benefits of IVUS in improving the outcomes of cardiovascular procedures.
The growth in the IVUS market is driven by several factors, including technological advancements, increased prevalence of cardiovascular diseases, and rising demand for minimally invasive procedures. Technological innovations in IVUS systems, such as improved image resolution and user-friendly interfaces, make the technology more accessible and effective for physicians. The aging global population and lifestyle-related health issues have led to a higher incidence of cardiovascular diseases, subsequently increasing the need for advanced diagnostic and treatment technologies like IVUS. Additionally, there is a growing patient preference for minimally invasive procedures, which are less painful, carry fewer risks of infection, and have quicker recovery times compared to traditional surgeries. These factors, combined with supportive government initiatives and healthcare policies promoting advanced medical equipment, are crucial in driving the adoption and expansion of IVUS technologies in medical institutions worldwide.
Scope of Study:
The report analyzes the Intravascular Ultrasound (IVUS) market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Product (IVUS Catheters, IVUS Consoles, Other Products); Application (Coronary Intervention, Coronary Diagnosis, Coronary Research, Non-Coronary/Peripheral); End-Use (Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Other End-Uses)
- Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the IVUS Catheters segment, which is expected to reach US$659.0 Million by 2030 with a CAGR of a 8.4%. The IVUS Consoles segment is also set to grow at 6.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $266.5 Million in 2024, and China, forecasted to grow at an impressive 10.1% CAGR to reach $199.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Intravascular Ultrasound (IVUS) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Intravascular Ultrasound (IVUS) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Intravascular Ultrasound (IVUS) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Johnson & Johnson Services, Inc., Boston Scientific Corporation, Terumo Corporation, Teleflex, Inc., Siemens Healthineers AG and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 15 companies featured in this Intravascular Ultrasound (IVUS) market report include:
- Johnson & Johnson Services, Inc.
- Boston Scientific Corporation
- Terumo Corporation
- Teleflex, Inc.
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Pie Medical Imaging BV
- ACIST Medical Systems, Inc.
- Avinger, Inc.
- InfraReDx, Inc.
- Philips Healthcare USA
- Clarius Mobile Health Corporation
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson Services, Inc.
- Boston Scientific Corporation
- Terumo Corporation
- Teleflex, Inc.
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Pie Medical Imaging BV
- ACIST Medical Systems, Inc.
- Avinger, Inc.
- InfraReDx, Inc.
- Philips Healthcare USA
- Clarius Mobile Health Corporation
